About Dylan Sammut
Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.
by Dylan Sammut | Jul 27, 2023 4:12 pm | Hospitals
Despite industry headwinds, one of the country’s largest health systems reported higher revenues in its quarterly earnings. HCA, Inc.’s revenues in the second quarter of 2023 increased to $15.9 billion, compared to $14.8 billion in the second quarter of 2022,... Read More »
by Dylan Sammut | Jul 27, 2023 4:10 pm | Hospitals
Tampa General Hospital has agreed to buy three Florida-based hospitals from a subsidiary of Community Health Systems. The hospitals, which collectively make up the Bravera Health network, include 120-bed Bravera Health Brooksville in Brooksville, Florida,... Read More »
by Dylan Sammut | Jul 17, 2023 3:53 pm | Private Equity
Despite some market woes, private equity remained bullish in the healthcare market for the second quarter of 2023. Deal volume from PE hit 216 transactions, a significant increase from the 191 announced in the first quarter of 2023, according to data captured in the... Read More »
by Dylan Sammut | Jul 5, 2023 4:16 pm | Home Health & Hospice
How would someone describe Optum, exactly? Some would define it as the most significant division of UnitedHealth Group, one of the country’s largest health insurance and managed care providers. Others would highlight its national pharmacy offerings, or its physician... Read More »
by Dylan Sammut | Jun 5, 2023 3:44 pm | Home Health & Hospice
Amedisys is the hot target of the second quarter. Early in May, Option Care Health, the largest independent home and alternate site infusion services provider in the United States, offered $3.6 billion to acquire a 64.5% stake in Amedisys and its multi-state home... Read More »